Tower Research Capital (TRC)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,703
| Closed | -$130K | – | 6794 |
|
|
2022
Q4 | $130K | Buy |
8,703
+5,964
| +218% | +$82.6K | 0.01% | 1625 |
|
|
2022
Q3 | $23K | Buy |
2,739
+2,106
| +333% | +$16.2K | ﹤0.01% | 3843 |
|
|
2022
Q2 | $4K | Sell |
633
-813
| -56% | -$3.94K | ﹤0.01% | 5337 |
|
|
2022
Q1 | $8K | Sell |
1,446
-12,049
| -89% | -$49.6K | ﹤0.01% | 4668 |
|
|
2021
Q4 | $63K | Buy |
13,495
+10,360
| +330% | +$64.3K | ﹤0.01% | 2591 |
|
|
2021
Q3 | $20K | Sell |
3,135
-25,629
| -89% | -$153K | ﹤0.01% | 3742 |
|
|
2021
Q2 | $190K | Buy |
28,764
+22,649
| +370% | +$156K | ﹤0.01% | 1970 |
|
|
2021
Q1 | $45K | Buy |
6,115
+1,502
| +33% | +$13K | ﹤0.01% | 3230 |
|
|
2020
Q4 | $27K | Sell |
4,613
-10,181
| -69% | -$58.3K | ﹤0.01% | 3677 |
|
|
2020
Q3 | $88K | Buy |
14,794
+12,417
| +522% | +$61.4K | ﹤0.01% | 3245 |
|
|
2020
Q2 | $12K | Buy |
2,377
+2,375
| +118,750% | +$15K | ﹤0.01% | 3954 |
|
|
2020
Q1 | $0 | Buy |
+2
| New | +$10 | ﹤0.01% | 4436 |
|
|
2019
Q4 | – | Sell |
-1,471
| Closed | -$12K | – | 4826 |
|
|
2019
Q3 | $12K | Sell |
1,471
-1,042
| -41% | -$7.75K | ﹤0.01% | 2850 |
|
|
2019
Q2 | $17K | Buy |
2,513
+1,863
| +287% | +$16K | ﹤0.01% | 2289 |
|
|
2019
Q1 | $5K | Sell |
650
-438
| -40% | -$4.52K | ﹤0.01% | 3127 |
|
|
2018
Q4 | $17K | Sell |
1,088
-515
| -32% | -$11.3K | ﹤0.01% | 2084 |
|
|
2018
Q3 | $53K | Buy |
1,603
+403
| +34% | +$10.4K | ﹤0.01% | 1725 |
|
|
2018
Q2 | $27K | Buy |
1,200
+1,179
| +5,614% | +$28K | ﹤0.01% | 2255 |
|
|
2018
Q1 | $1K | Sell |
21
-3,417
| -99% | -$100K | ﹤0.01% | 3142 |
|
|
2017
Q4 | $96K | Buy |
+3,438
| New | +$107K | 0.01% | 895 |
|
|
2017
Q1 | – | Sell |
-108
| Closed | -$1K | – | 4309 |
|
|
2016
Q4 | $1K | Sell |
108
-4,426
| -98% | -$29.5K | ﹤0.01% | 3712 |
|
|
2016
Q3 | $40K | Buy |
4,534
+1,150
| +34% | +$10.8K | ﹤0.01% | 1262 |
|
|
2016
Q2 | $33K | Buy |
3,384
+3,220
| +1,963% | +$31K | ﹤0.01% | 1872 |
|
|
2016
Q1 | $1K | Sell |
164
-99
| -38% | -$980 | ﹤0.01% | 3895 |
|
|
2015
Q4 | $3K | Sell |
263
-556
| -68% | -$6.61K | ﹤0.01% | 3577 |
|
|
2015
Q3 | $10K | Buy |
819
+677
| +477% | +$9.78K | ﹤0.01% | 2338 |
|
|
2015
Q2 | $2K | Buy |
+142
| New | +$2.56K | ﹤0.01% | 3844 |
|
|
2014
Q4 | – | Sell |
-10
| Closed | – | – | 5007 |
|
|
2014
Q3 | $0 | Buy |
+10
| New | +$127 | ﹤0.01% | 5104 |
|
|
2014
Q2 | – | Sell |
-1,950
| Closed | -$29K | – | 4890 |
|
|
2014
Q1 | $29K | Buy |
+1,950
| New | +$35K | ﹤0.01% | 1547 |
|
|
2013
Q3 | – | Sell |
-400
| Closed | -$10K | – | 4983 |
|
|
2013
Q2 | $10K | Buy |
+400
| New | +$17.1K | ﹤0.01% | 2395 |
|
Tower Research Capital (TRC)'s AVEO Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 8,703 shares — an estimated $130K sold.
Tower Research Capital (TRC) first reported a position in AVEO in Q2 2013 and held it in 30 quarters. The position peaked at $190K in Q2 2021. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 8,703 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $130K.
- Tower Research Capital (TRC) first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Tower Research Capital (TRC)'s AVEO Pharmaceuticals, Inc. position peaked at $190K in Q2 2021.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.